Company Filing History:
Years Active: 2000
Title: Innovations of Patrick W Lee in Cancer Treatment
Introduction
Patrick W Lee is a notable inventor based in Calgary, Canada, recognized for his contributions to the field of cancer treatment. He holds two patents that focus on the use of reovirus in treating cellular proliferative disorders and neoplasia. His innovative approaches aim to provide effective therapies for patients suffering from various types of neoplasms.
Latest Patents
Patrick W Lee's latest patents include methods for treating proliferative disorders by administering reovirus to Ras-mediated proliferating cells. The reovirus is designed to directly contact these cells, targeting conditions such as neoplasms. His patents detail the use of human reovirus, non-human mammalian reovirus, and avian reovirus, with specific strains mentioned, including serotype 1 (strain Lang), serotype 2 (strain Jones), and serotype 3 (strains Dearing and Abney). The methods outlined can treat both solid neoplasms and hematopoietic neoplasms, showcasing the versatility of reovirus in therapeutic applications.
Career Highlights
Patrick W Lee is currently associated with Oncolytics Biotech Inc., a company dedicated to advancing cancer therapies. His work has significantly contributed to the understanding and application of oncolytic virotherapy, which utilizes viruses to selectively target and destroy cancer cells. His innovative research has positioned him as a key figure in the field of oncology.
Collaborations
Some of his notable coworkers include James Strong and Matthew C Coffey, who collaborate with him in advancing the research and development of cancer treatment methodologies.
Conclusion
Patrick W Lee's innovative work in the field of cancer treatment through the use of reovirus represents a significant advancement in therapeutic options for patients. His contributions continue to shape the landscape of oncology and offer hope for improved treatment outcomes.